Earlier this week, the FDA approved GSK’s antibiotic, gepotidacin (Blujepa). The treatment is indicated for

March 28, 2025 No Comments

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its

March 28, 2025 No Comments

The Health and Human Services (HHS) department announced yesterday it is planning on a major

March 28, 2025 No Comments

In the second installment of our interview with Robert Hopkins Jr, MD, the medical director

March 27, 2025 No Comments

Redwood City, Calif-based Bluejay Therapeutics, announced yesterday it had dosed the first patient in their clinical

March 27, 2025 No Comments

COVID infection has been linked to higher risk of autoimmune disorders, including rheumatoid arthritis and

March 26, 2025 No Comments

This photograph depicts a child who was infected with the measles during a US outbreak

March 26, 2025 No Comments

Theratechnologies has received FDA approval for its supplemental Biologics License Application (sBLA) for EGRIFTA WR

March 26, 2025 No Comments

The FDA has approved Theratechnologies’ supplemental Biologics License Application (sBLA) for EGRIFTA WR (Tesamorelin F8),

March 26, 2025 No Comments

The FDA has approved Theratechnologies’ supplemental Biologics License Application (sBLA) for EGRIFTA WR (Tesamorelin F8),

March 25, 2025 No Comments

Schedule an Appointment

Quick Links